Award

Supply and Support of REBOA

  • Leidos Supply

F15: Voluntary ex ante transparency notice

Notice identifier: 2022/S 000-031968

Procurement identifier (OCID): ocds-h6vhtk-03837e

Published 11 November 2022, 11:10am



Section one: Contracting authority/entity

one.1) Name and addresses

Leidos Supply

Monarch Court, 8 The Brooms, Emersons Green

Bristol

Email

Samuel.Harrison@leidos.com

Country

United Kingdom

Region code

UK - United Kingdom

Internet address(es)

Main address

https://www.leidos-supply.uk/

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Defence


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Supply and Support of REBOA

two.1.2) Main CPV code

  • 33141210 - Balloon catheters

two.1.3) Type of contract

Supplies

two.1.4) Short description

Leidos Supply Ltd intends to award a framework agreement to Prytime Medical Devices Inc for the supply and support of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA).

This agreement will last for up to 3 years.

Please note, this is NOT a request for companies to express interest.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Lowest offer: £272,000 / Highest offer: £680,000 taken into consideration

two.2) Description

two.2.2) Additional CPV code(s)

  • 33141210 - Balloon catheters
  • 33621200 - Antihaemorrhagics

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement

Leidos Supply Ltd intends to award a framework agreement to Prytime Medical Devices Inc for the supply and support of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA).

This agreement will last for up to 3 years with an estimated value of £272,000 - £680,000.

It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32 (b)(ii) of Directive 2014/24/EC of the European parliament and of the council (regulation 32(2) (ii) of PCR 2015). Under regulation 32 (2)(b)(ii) of the Public Contract Regulations 2015 using the negotiated procedure without prior publication when competition is absent for technical reasons.

Prytime Medical Devices Inc are the sole vendor to the UK for the main REBOA devices (catheter and catheter kit) required by the Ministry of Defence customer.

If a company was selected that is not manufacturer approved then this could alter the performance characteristics of the devices, as well as potentially incurring significant medical malpractice claims.

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The contract has its object services listed in Annex II B

Explanation:

Please explain in a clear and comprehensive manner why the award of the contract without prior publication in the Official Journal of the European Union is lawful, by stating the relevant facts and, as appropriate, the conclusions of law in accordance with the directive: (500 words maximum)

Leidos Supply Ltd intends to award a framework agreement to Prytime Medical Devices Inc for the supply and support of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA).

This agreement will last for up to 3 years with an estimated value of £272,000 - £680,000.

It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32 (b)(ii) of Directive 2014/24/EC of the European parliament and of the council (regulation 32(2) (ii) of PCR 2015). Under regulation 32 (2)(b)(ii) of the Public Contract Regulations 2015 using the negotiated procedure without prior publication when competition is absent for technical reasons.

Prytime Medical Devices Inc are the sole vendor to the UK for the main REBOA devices (catheter and catheter kit) required by the Ministry of Defence customer.

If a company was selected that is not manufacturer approved then this could alter the performance characteristics of the devices, as well as potentially incurring significant medical malpractice claims.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract/concession

Contract No

LSL/MED/0130

A contract/lot is awarded: Yes

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract

4 November 2022

five.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

Prytime Medical Devices Inc

Boerne, TX

Country

United States

NUTS code
  • US - United States
The contractor/concessionaire is an SME

No

five.2.4) Information on value of contract/lot/concession (excluding VAT)

Lowest offer: £272,000 / Highest offer: £680,000 taken into consideration

five.2.5) Information about subcontracting

The contract/lot/concession is likely to be subcontracted


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Leidos Supply Ltd

Bristol

Country

United Kingdom